By
Marissa Chmiola
Published: Aug. 22, 2014, 12:29 p.m.·
Tags:
Treatment,
Drug-resistant TB
Laia Ruiz Mingote and Dorothy Namutamba—co-chairs of CRAG— and Mike Watson Frick—TB/HIV Program Officer at Treatment Action Group—discuss the benefits and risks of using bedaquiline to treat TB.
Read More →